Status:
RECRUITING
Evaluation of Intestinal Lesions and Disease Activity in Inflammatory Bowel Disease Based on 18F-FAPI PET Imaging
Lead Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Conditions:
Inflammatory Bowel Disease (IBD)
Disease Activity
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to evaluate the role and effect of 18F-FAPI PET imaging in the identification of intestinal lesions and the assessment of disease activity in inflammatory bowel...
Eligibility Criteria
Inclusion
- Patients diagnosed with IBD according to clinical, imaging, endoscopic, and histopathological criteria;
- Patients ≥18 years old;
- 18F-FAPI PET/CT intestinal imaging, conventional endoscopic and enhanced CT were performed within 1 week;
- Intestinal segment matching was evaluated by endoscopy and imaging;
- Patients voluntarily participate and sign informed consent.
Exclusion
- Pregnant or lactating patients;
- Imaging images are of poor quality and cannot be used for diagnosis and evaluation;
- Patients with contraindications for endoscopic or CT examination.
Key Trial Info
Start Date :
April 25 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06945549
Start Date
April 25 2025
End Date
December 31 2027
Last Update
June 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Army Medical Center of PLA, Daping Hospital, Army Medical University
Chongqing, Chongqing Municipality, China, 400042